A-A-54563
31 December 1991
COMMERCIAL ITEM DESCRIPTION
LIDOCAINE HYDROCHLORIDE JELLY, USP
The General Services Administration has authorized the use of this Commercial Item Description as a replacement for Military Specification MIL-L-37876 which is cancelled.
Salient characteristics:
Shall be Lidocaine Hydrochloride Jelly, USP.
Shall be in accordance with the requirements of the USP.
All ingredients shall be of a pharmaceutical grade.
Shall contain 2% Lidocaine Hydrochloride (w/v) within the applicable assay limits for the jelly.
Workmanship. The jelly shall be free from defects which detract from its appearance or impair its serviceability.
Unit.
For Size 1 – Shall be supplied 5 ml in a sterile vial injector unit. One package containing 25 sterile vial injector units, as specified, constitutes one unit.
For Size 2 – Shall be supplied 10 ml in a sterile vial injector unit. One package containing 25 sterile vial injector units, as specified, constitutes one unit.
For Size 2 – Shall be supplied 20 ml in a sterile vial injector unit. One package containing 25 sterile vial injector units, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business